![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_8d5e8c09b928f0a0d7ef2a922fa74e82.svg) | 3-Aminoquinoxalin-2(1H)-one | Ki | 20.8 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_cd1b736b374f0f01d2c8c2f5aeeb79b3.svg) | 2-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_2c31a78a4c2b8a1a593cdc3876aab93b.svg) | 6,12-Dihydroquinoxalino[2,3-b][1,4]benzodiazepin-13-one | Ki | 1.33 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_82be06968aeb79973dabad090f9cf139.svg) | 2-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,40S,43R,49S)-25-(4-Aminobutyl)-49-benzyl-4,19-bis[(2S)-butan-2-yl]-34-[3-(diaminomethylideneamino)propyl]-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-3,6,12,18,21,24,27,30,33,36,39,42,48,51-tetradecaoxo-53,54-dithia-2,5,11,17,20,23,26,29,32,35,38,41,47,50-tetradecazapentacyclo[29.20.4.07,11.013,17.043,47]pentapentacontan-40-yl]acetic acid | Ki | 500000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_41c12db5ad12d2430619223e0127217c.svg) | 3-(1H-Benzimidazol-2-yl)-1-(1H-benzimidazol-2-ylmethyl)-5-phenylpyrrol-2-amine | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_5c716b8d32e32ab603c5c45dbfc3cad7.svg) | 6-(1H-Benzimidazol-2-ylmethyl)-11H-quinoxalino[2,3-b][1,4]benzodiazepin-13-one | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_be96980a30e9fa5ce2f1e85cf693739c.svg) | 2-Amino-1-(1H-benzimidazol-2-ylmethyl)-5-phenyl-pyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_6cb46b33493cb7faf4ccf4cec240a5c9.svg) | 3-(1H-Benzimidazol-2-yl)-5-phenyl-1-(2-pyridyl)pyrrol-2-amine | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_872de49283f53e0f89a9a0613f04c564.svg) | 3-(1H-Benzimidazol-2-yl)-1-(3-chlorophenyl)-5-phenylpyrrol-2-amine | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_e77cfc77b02d5aa2e672f7b86d2e17db.svg) | 6-[(1-Prop-2-enylbenzimidazol-2-yl)methyl]-11H-quinoxalino[2,3-b][1,4]benzodiazepin-13-one | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_4db752833502bbb594f99d52f235c99a.svg) | 2-Amino-1-(1H-benzimidazol-2-yl)-5-phenyl-pyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_4ce7572c99ede4f1b22dfa73339336c4.svg) | 3-(1H-Benzimidazol-2-yl)-5-phenyl-1-(4-pyridyl)pyrrol-2-amine | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_2c16f33486711286fc61b7014955fd65.svg) | 3-(1H-Benzimidazol-2-yl)-1-(4-bromophenyl)-5-phenyl-pyrrol-2-amine | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_93c7b41091420a4ef62c15f8ded8a7a6.svg) | Ethyl 2-[2-[(13-oxo-11H-quinoxalino[2,3-b][1,4]benzodiazepin-6-yl)methyl]benzimidazol-1-yl]acetate | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_59c3193da4f9b15707c3eb6c5ec61e8b.svg) | 3-(1H-Benzimidazol-2-yl)-1-(3-bromophenyl)-5-phenyl-pyrrol-2-amine | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_de05146e7ca25d95e8ca6db33fedbfd9.svg) | 1,3-Bis(1H-benzimidazol-2-yl)-5-phenyl-pyrrol-2-amine | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_83676417698058fb6dd8834f17cc01a2.svg) | 3-(1H-Benzimidazol-2-yl)-1-(4-chlorophenyl)-5-phenylpyrrol-2-amine | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_03fa14bd0237761f4af56a3456fe6330.svg) | 2-Amino-1-(4-chlorophenyl)-5-phenylpyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_4dc545f4471ed413d15ef0009d4ad6b9.svg) | 2-Amino-1-(3-chlorophenyl)-5-phenylpyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_fdad568d20bccae86a2e4bde44f8d6d1.svg) | 2-Amino-1-(4-bromophenyl)-5-phenylpyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_a18f4d5a9b1cf44bc95683daf009cc65.svg) | 3-[[12-(3-Ethoxycarbonylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid | IC50 | 51000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_a01d66559be1b951ddf15eb1d5d6a37b.svg) | 4-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]butanoic acid | IC50 | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_70a7498b28da36612122309655670747.svg) | 4-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]butanoic acid | IC50 | 36000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_58c7271debec4bd6db1ab658b9bcbbe1.svg) | 3-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid | IC50 | 24000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_da0be9bebad24719063eae602211b5d2.svg) | 2-[(8-Oxo-12-pyrrolidin-1-yl-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl)amino]benzoic acid | IC50 | 21000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_0cbb186fd8324596b6c55c36e6ee1c46.svg) | 3-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 7000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_8e4438f99e51876c85cae752b0e1fee3.svg) | 3-[[12-(2-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_4cee6aeb3f3cd522f7d3643ccba82390.svg) | 3-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 5000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_d2e4d4e7a6108b515f69f20396efb283.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21S,26S,29R)-21-amino-3,18-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_00e98dc827d3e1a3af4de2ab2041cded.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15R,18R,21S,26S,29R)-21-amino-15-(4-aminobutyl)-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_3686705bdf36ddd9d161c3c1bd386e2c.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18S,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_9744ebbb00494be8001e1afce030d0e9.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_25729f9db65c6d03df0d63d7166f8efe.svg) | (3S,6R,9S,12R,15S,18R,21S,27S,32S,35R,38S,41R)-27-Amino-18,35-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-21,38-bis(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,34,37,40-dodecaoxo-3-propan-2-yl-29,30-dithia-1,4,7,10,13,16,19,22,25,33,36,39-dodecazabicyclo[39.3.0]tetratetracontane-32-carboxylic acid | IC50 | 700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_cb4c3687e670db90ff82f2d50c555578.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(naphthalen-2-ylmethyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 80.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_efae851ef26658a6d11892923baae936.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(naphthalen-1-ylmethyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 50.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_100dbec8b6514f3bc11ee0412a7de812.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-butyl-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_93850e4e2488dbba93872058c67f6503.svg) | (3S,6R,9S,12R,15S,18R,21S,27R,32S,35R,38S,41R)-27-Amino-18,35-bis(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-21,38-bis(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,34,37,40-dodecaoxo-3-propan-2-yl-29,30-dithia-1,4,7,10,13,16,19,22,25,33,36,39-dodecazabicyclo[39.3.0]tetratetracontane-32-carboxylic acid | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_e081055804e00ed2e5bba9fb75288003.svg) | (2S)-4-Amino-2-[[(3S,6R,9S,12R,15S,18R,21R,26R,29R)-21-amino-18-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-15-(2-carboxyethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 40.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_ba8be98b3143afd798f37cd28caa63eb.svg) | (2S)-4-Amino-2-[[(3S,6S,9S,12R,15S,18R,21S,26S,29R)-21-amino-18-(2-amino-2-oxoethyl)-15-(2-carboxyethyl)-6-(hydroxymethyl)-9-(1H-imidazol-5-ylmethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20,28-octaoxo-3-propan-2-yl-23,24-dithia-1,4,7,10,13,16,19,27-octazabicyclo[27.3.0]dotriacontane-26-carbonyl]amino]-4-oxobutanoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_8c3f5daa1a08937d0ef6f9f3462be560.svg) | 3-[[12-(3,5-Dimethylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]propanoic acid | IC50 | 18000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_0648f768254d3966576b4f84514b236b.svg) | 4-[[8-Oxo-12-(4-oxopiperidin-1-yl)-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_737c5d38641b202d940b21e6f92f11b5.svg) | 4-[[[3-(1,3-Benzodioxol-5-yl)-4-phenylbutyl]amino]methyl]-N,N-dimethylaniline | Ki | 20000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_e92f072ef74b96a691c72e41af5b7d0b.svg) | 2-Phenacylpropanedinitrile | Ki | 0.3 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_1a1ba9c02fa992d64c2f76651aba10ab.svg) | Methyl 3-[[12-(azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoate | IC50 | 100000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_5b42ff9166a2dd6bb241bb33f796956b.svg) | 3-[(3-Bromo-4-hydroxy-6,7-dimethyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid | IC50 | 67000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_7e66b7cd430c17fda2fcf97c441a91c8.svg) | 2-Amino-5-phenyl-1-pyridin-4-ylpyrrole-3-carbonitrile | Ki | 0.01 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_fd105bea842a511d72e8cadfd195333e.svg) | 3-[(3-Bromo-9,10-dioxo-4-propan-2-yloxyanthracen-1-yl)amino]benzoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_da2086dd9642c0dd0a44ff6b2d7ca6ac.svg) | 3-[(3-Bromo-4-hydroxy-6-methyl-9,10-dioxoanthracen-1-yl)amino]benzoic acid | IC50 | 146000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_cbd683a76069b8bdd7ddcdd6ab097f9a.svg) | 2-Amino-5-phenyl-1-pyridin-2-ylpyrrole-3-carbonitrile | Ki | 0.03 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_f420cda05839d8cdf1bf8029a429e620.svg) | 3-[(3-Bromo-9,10-dioxo-4-phenylmethoxyanthracen-1-yl)amino]benzoic acid | IC50 | 30000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_0105b26b347ec9476c60667d6711f7e9.svg) | 4-[[12-(3-Methylpiperidin-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]methyl]benzoic acid | IC50 | 11000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_5e2771ba5279846171413a47bc57193a.svg) | 2-Amino-1-(3-bromophenyl)-5-phenylpyrrole-3-carbonitrile | Ki | 0.0 [1] |
![](https://images.aatbio.com/dataset/ic50/urokinase-plasminogen-activator-surface-receptor_7976cb82673697494e6609e614a9d946.svg) | 2-[[12-[(3S,5S)-3,5-Dimethylpiperidin-1-yl]-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid | IC50 | 10000.0 [1] |